NCT04561089View on ClinicalTrials.gov

Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel

CompletedOBSERVATIONAL
Enrollment

763

Participants

Timeline

Start Date

February 13, 2020

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
SARS-CoV-2
Interventions
DIAGNOSTIC_TEST

COVIDSeq Test

The COVIDSeq is designed to test RNA extracted from NP swab specimens from patients symptomatic for COVID-19

Trial Locations (3)

92122

Illumina Laboratory Services, San Diego

94404

Illumina Laboratory Services, Foster City

94545

Illumina Hayward, Hayward

Sponsors

Lead Sponsor

Illumina, Inc.
All Listed Sponsors
collaborator

Helix OpCo, LLC

UNKNOWN

lead

Illumina, Inc.

INDUSTRY